Modification of the renal toxicity of cis-dichlorodiammineplatinum(II) with furosemide in male F344 rats.

No abstract is available for this paper.

• Publication year

  1977

• Venue

  Cancer treatment reports

• Publication date

  1977-05-01

• Fields of study

  Medicine

• Identifiers
  PMID 872137
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevention of renal failure in rats receiving cis-diamminedichloroplatinum(II) by administration of furosemide.

  1977cited by this paper
• Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSC 119875) to dogs.

  1976cited by this paper
• Chemotherapy: renewed interest in platinum compounds.

  1976cited by this paper
• Comparative nephrotoxicity of platinum cancer chemotherapeutic agents.

  1976cited by this paper
• The nephrotoxic effects of cis-diammine-dichloroplatinum (II) (NSC-119875) in male F344 rats.

  1976cited by this paper
• Review of the current clinical status of platinum coordination complexes in cancer chemotherapy.

  1975cited by this paper
• Platinum nephrotoxicity

  1974cited by this paper
• cis-Dichlorodiammineplatinum(II) (NSC-119 875): preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice.

  1973cited by this paper
• The use of mannitol to reduce the nephrotoxicity of amphotericin B.

  1972cited by this paper
• Antileukaemic and Nephrotoxic Properties of Platinum Compounds

  1971cited by this paper
• Acute toxicologic and pathologic effects of cis-diamminedichloroplatinum (NSC-119875) in the male rat.

  1971cited by this paper
• Platinum Compounds: a New Class of Potent Antitumour Agents

  1969cited by this paper
• THE SITE OF ACTION OF FUROSEMIDE AND OTHER SULFONAMIDE DIURETICS IN THE DOG.

  1965cited by this paper
• PREVENTION OF POSTOPERATIVE ACUTE RENAL FAILURE WITH MANNITOL IN 100 CASES.

  1964cited by this paper
• Determination of urea nitrogen with the diacetyl method and an automatic dialyzing apparatus.

  1957cited by this paper

• Nefrotoxicidade da Cisplatina

  2023cites this paper
• Effect of mannitol on acute kidney injury induced by cisplatin

  2020cites this paper
• Toxicity to Host-renewing Cell Populations in Rats Cis-Dichlorodiammineplatinum(II) Antitumor Activity and Effects of Mannitol or Furosemide Diuresis on

  2013cites this paper
• Therapeutic use of D-methionine to reduce the toxicity of noise

  2007cites this paper
• Synthesis without Compromising Its Antitumor Activity in Mice-Diamminedichloroplatinum ( II ) by Induction of Metallothionein cis Prevention of Lethal and Renal Toxicity of Updated

  2006cites this paper
• Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration

  2004cites this paper
• A comparative study of the distribution in the male rat of platinum-labelled cis-dichlorodiammine platinum (II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (I), and cis-dichloro-bis-cyclopropylamine platinum (II)

  2004cites this paper
• Effects of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: protective mechanism against cisplatin nephrotoxicity

  2004cites this paper
• Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial

  2003cites this paper
• Association of cisplatin nephrotoxicity with patient characteristics and cisplatin administration methods

  1997cites this paper
• The renal clearance of unchanged cisplatin during furosemide and mannitol diuresis is dependent on glomerular filtration rate in rats.

  1996cites this paper
• Protective effects of KW-3902, an adenosine A1-receptor antagonist, against cisplatin-induced acute renal failure in rats.

  1995cites this paper
• Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin.

  1993cites this paper
• Mechanism of polyuria after cisplatin therapy.

  1993cites this paper
• Platinum antitumour agents: A review of (bio)analysis

  1992cites this paper
• Acute nephrotoxicity as an adverse effect after intraperitoneal injection of massive amounts of bioactive ceramic powders in mice and rats.

  1992cites this paper
• Protection against cis-diamminedichloroplatinum-induced nephrotoxicity in rats by N-benzyl-D-glucamine dithiocarbamate.

  1991cites this paper
• Cisplatin nephrotoxicity: experimental and clinical studies.

  1990cites this paper
• Long‐term effects of acetazolamide and sodium chloride loading on cisplatin nephrotoxicity in the rat

  1990cites this paper
• The combined effect of cisplatin and furosemide on hearing function in guinea pigs.

  1989cites this paper
• Protective effect of piperacillin against the nephrotoxicity of cisplatin in rats

  1989cites this paper
• Effect of aminophylline on cisplatin nephrotoxicity in the rat

  1989cites this paper
• The effects of platinum levels in plasma, urine, and kidney on blood urea nitrogen levels after cisplatin injection in rats.

  1988cites this paper
• Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice.

  1987cites this paper
• Nephrotoxicity and carcinogenic risk of cis-platin (CDDP) prevented by sodium 2-mercaptoethane-sulfonate (Mesna): experimental results.

  1987cites this paper
• Functional and histopathological changes in dog kidneys after administration of cisplatin.

  1987cites this paper
• Acute systemic toxicity of combined cis-diamminedichloroplatinum and hyperthermia in the rat.

  1987cites this paper
• Pharmacokinetic Drug Interactions of Commonly Used Anticancer Drugs

  1986cites this paper
• Pharmacokinetics of cis-diamminedichloroplatinum(II) after administration in hypertonic saline.

  1986cites this paper
• Reduction of the drug-induced nephrotoxicity by ATP-MgCl2. 1. Effects on the cis-diamminedichloroplatinum-treated isolated perfused kidneys.

  1985cites this paper
• Renal and hepatic concentrations of platinum: relationship to cisplatin time, dose, and nephrotoxicity.

  1985cites this paper
• Renal elimination of the hypoxic cell radiosensitizer misonidazole in wistar rats: influence of some drugs on its excretion

  1985cites this paper
• The renal fractional clearance of platinum antitumour compounds in relation to nephrotoxicity.

  1985cites this paper
• Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function.

  1984cites this paper
• cis-Diamminedichloroplatinum(II): effects of a representative metal coordination complex on mammalian cells.

  1984cites this paper
• Effect of probenecid and N'-methylnicotinamide on renal handling of cis-dichlorodiammineplatinum-II in rats.

  1983cites this paper
• Improvement in the therapeutic index of cisplatin (NSC 119875) by pharmacologically induced chloruresis in the rat.

  1983cites this paper
• Effect of mannitol and plasma on the cytotoxicity of cisplatin.

  1983cites this paper
• Are Diuretics Useful in the Treatment or Prevention of Acute Renal Failure?

  1982cites this paper
• Early polyuria in the rat following single-dose cis-dichlorodiammineplatinum (II): effects on plasma vasopressin concentration and posterior pituitary function.

  1982cites this paper
• The renal toxicity of cancer chemotherapeutic agents.

  1982cites this paper
• Cisplatin-induced nephrotoxicity.

  1982cites this paper
• Lethal nephrotoxicity and hematologic toxicity of cis-diamminedichloroplatinum ameliorated by optimal circadian timing and hydration.

  1982cites this paper
• Alterations in the toxicity of cis-dichlorodiammineplatinum-II and in tissue localization of platinum as a function of NaCl concentration in the vehicle of administration.

  1981cites this paper
• Safe and effective two-hour outpatient regimen of hydration and diuresis for the administration of cis-diamminedichloroplatinum (II).

  1981cites this paper
• Synthesizing activity and ultrastructural findings of human blood cells after incubation with cis-platinum "in vitro".

  1981cites this paper
• High-dose cisplatin therapy using mannitol versus furosemide diuresis: comparative pharmacokinetics and toxicity.

  1981cites this paper
• Methods of reduction of cisplatin nephrotoxicity.

  1981cites this paper
• Mechanism of cis-platinum nephrotoxicity: I. Effects of sulfhydryl groups in rat kidneys.

  1980cites this paper
• Toxicity of Cis‐diamminedichloroplatinum II given in a two‐hour outpatient regimen of diuresis and hydration

  1980cites this paper
• Effects of mannitol or furosemide diuresis on cis-dichlorodiammineplatinum(II) antitumor activity and toxicity to host-renewing cell populations in rats.

  1979cites this paper
• Gallium nitrate (NSC‐15200) induced toxicity in the rat. A pharmacologic, histopathologic and microanalytical investigation

  1979cites this paper
• Effect of a forced diuresis on the distribution and excretion (via urine and bile) of 195mplatinum when given as 195mplatinum cis-dichlorodiammineplatinum(II).

  1979cites this paper
• The effect of diuretic pre-treatment on clinical, morphological and ultrastructural cis-platinum induced nephrotoxicity.

  1979cites this paper
• Effects of mannitol or furosemide diuresis on the nephrotoxicity and physiological disposition of cis-dichlorodiammineplatinum-(II) in rats.

  1979cites this paper
• Combination chemotherapy with cis-diammine-dichloro-platinum, vinblastine, and bleomycin in advanced testicular non-seminoma.

  1979cites this paper
• Kinetics of cis‐dichlorodiammineplatinum

  1979cites this paper
• Reduction of the renal toxicity of cis-dichlorodiammineplatinum(II) by probenecid.

  1979cites this paper